Kalvista Pharmaceuticals Inc
SWB:4XC1
Kalvista Pharmaceuticals Inc
SWB:4XC1
Price:
22.8
EUR
0.18%
Market Closed
Market Cap:
€503.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
K
|
Kalvista Pharmaceuticals Inc
SWB:4XC1
|
US |
|
L
|
Lagardere SA
XMUN:LAG
|
FR |
|
G
|
Glaukos Corp
F:6GJ
|
US |
Wall St Price Targets
4XC1 Price Targets Summary
Kalvista Pharmaceuticals Inc
Kalvista Pharmaceuticals Inc
Wall Street analysts forecast 4XC1 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 4XC1 is 25.78 EUR with a low forecast of 23.07 EUR and a high forecast of 31.98 EUR.
Lowest Forecast
Price Target
23.07
EUR
1% Upside
Average Forecast
Price Target
25.78
EUR
13% Upside
Highest Forecast
Price Target
31.98
EUR
40% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 4XC1's stock price target?
Price Target
25.78
EUR
25.78
EUR
According to Wall Street analysts, the average 1-year price target for 4XC1 is 25.78 EUR with a low forecast of 23.07 EUR and a high forecast of 31.98 EUR.
What is the Revenue forecast for Kalvista Pharmaceuticals Inc?
Projected CAGR
39%
39%
Over the last 12 years, the compound annual growth rate for Revenue has been 49%. The projected CAGR for the next 8 years is 39%.
